Coronavirus Updates

Important Coronavirus Vaccine Information:     

On January 3, 2022 the Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to expand the use of a single booster dose to include use in individuals 12 through 15 years of age. Also, starting today, they are allowing for a third primary series dose for certain immunocompromised children 5 through 11 years of age.  FDA Press Release.

On December 9, 2021 the Center for Disease Control expanded Covid-19 booster reccomedations to 16 and 17 year olds. At this time only the Pfizer-BioNTech COVID-19 vaccine is authoriazed for use as a booster in that age group. CDC Press Release.

On November 19, 2021 the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine.  FDA press release.


On November 2, 2021 the CDC approved the authorization of kid-sized Pfizer Covid-19 vaccinations. Children ages 5 to 11 are now eligible for a Pfizer vaccine effective immediately. CDC Press Release.


On October 20, 2021 the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amended the emergency use authorization (EUA) for COVID-19 vaccines to allow for the use of a single booster dose. FDA Press Release Here.


On September 22, 2021 the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series. This updated emergency authorization applies only to the Pfizer-BioNTech COVID-19 Vaccine.  FDA Press Announcement Here


On August 23, 2021 the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.   FDA Website.


At this time the Orange Board of Health is not holding any vaccination clinics.  We are still doing updates which are listed on this page as well as our Facebook page. We will update the public with any relevant Coronavirus information as needed. 

For more information on the coronavirus, visit the Massachusetts Website for Coronavirus Information or the Board of Health Facebook Page 

Feed